The role of TNF-α and PAI-1 gene polymorphisms in familial Mediterranean fever

Modern Rheumatology

Volumn 23, Issue 1, 2013, Pages 140-145

  Dundar, Munis ^a   Kiraz, Aslihan ^b   Balta, Burhan ^a   Emirogullari, Elif Funda ^a   Zararsiz, Gokmen ^a   Yurci, Alper ^a   Aslan, Duran ^a   Baskol, Mevlut ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Maternity and Children Hospital ^*  (Turkey)

Author keywords

Cytokine; Familial Mediterranean fever; PAI 1; Polymorphism; TNF

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; AGE OF ONSET; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; TURKEY; YOUNG ADULT;

EID: 84872501047     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0687-9     Document Type: Article

References (26)

1. YIlmaz R, Ozer S, Ozyurt H, Erkorkmaz U, Sahin S. Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype-phenotype correlation in children. J Paediatr Child Health. 2009;45:641-5.
2. Gunel Ozcan A, SayIn DB, Dibek Misirlioglu E, Guliter S, Yakaryilmaz F, Ensari C. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at KIrIkkale University in Turkey. Mol Biol Rep. 2009;36:757-60.
3. Balci-Peynircioglu B, Waite AL, Hu C, Richards N, Staubach-Grosse A, Yilmaz E, et al. Pyrin, product of the MEFV locus, interacts with the proapoptotic protein, Siva. J Cell Physiol. 2008;216:595-602.
4. Aksu G, Ozturk C, Kavakli K, Genel F, Kutukculer N. Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol. 2007;26:366-70.
5. Dundar M, Emirogullari EF, Kiraz A, Taheri S, Baskol M. Common familial Mediterranean fever gene mutations in a Turkish cohort. Mol Biol Rep. 2011;38:5065-9.
6. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity. 2011;34:755-68.
7. Ozel Demiralp D, Ekim M, Akar N. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease. Clin Appl Thromb Hemost. 2009;15:443-7.
8. Manukyan GP, Ghazaryan KA, Ktsoyan ZhA, Tatyan MV, Khachatryan ZA, Hakobyan GS, et al. Cytokine profile of Armenian patients with familial Mediterranean fever. Clin Biochem. 2008;41:920-2.
9. Vural P, Degirmencioglu S, Saral NY, Demirkan A, Akgul C, Yildirim G, et al. Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia. J Obstet Gynaecol Res. 2010;36:64-71.
10. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997;34:391-9.
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195-9.
12. Flick MJ, Du X, Witte DP, Jirouskova M, Soloviev DA, Busuttil SJ, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 2004;113:1596-606.
13. Gil W. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation. Perfusion. 2001;16:27-35.
14. Wingeyer SP, de Larranaga G, Cunto E, Fontana L, Nogueras C, San Juan J. Role of 4G/5G promoter polymorphism of plasminogen activator Inhibitor-1 (PAI-1) gene in outcome of sepsis. Thromb Res. 2010;125:367-9.
15. Emirogullari EF, Saatçi C, Ünal A, Şahin A, Ozkul Y. Prothrombin, factor-V Leiden and plasminogen activator inhibitor type 1 gene polymorphisms in hemodialysis patients with/without arteriovenous fistula thrombosis. Int J Nephrol Urol. 2010;2:314-9.
16. Papadopoulos VP, Giaglis S, Mitroulis I, Ritis K. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72:752-61.
17. Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol. 2003;22:99-101.
18. Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol. 1995;79:1497-503.
19. Schattner A, Gurevitz A, Zemer D, Hahn T. Induced TNF production in vitro as a test for familial Mediterranean fever. Q J Med. 1996;89:205-10.
20. Akar N, Hasipek M, Akar E, Ekim M, Yalcinkaya F, Cakar N. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid. 2003;10:12-6.
21. Yilmaz E, Balci B, Kutlay S, Ozen S, Erturk S, Oner A, et al. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr. 2003;45:198-202.
22. Karahan ZC, Ozturk A, Akar E, Akar N. Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis. J Nephrol. 2005;18:582-4.
23. Celebi Kobak A, Kobak S, Kabasakal Y, Akarca US. Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever. Clin Rheumatol. 2007;26:908-910.
24. Li XX, Li N, Ban CJ, Zhu M, Xiao B, Dai HP. Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-beta1 and plasminogen activator inhibitor 1. Chin Med J. 2011;124:1923-7.
25. Lima LM, Carvalho MD, Fonseca Neto CP, Garcia JC, Sousa MO. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease. Arq Bras Cardiol. 2011;97:462-7.
26. Sari I, Yuksel A, Kozaci D, et al. The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with FMF. Inflammation. 2012;35(3):1191-7.